Health Condition 1: I00-I99- Diseases of the circulatory system
Conditions
Interventions
Intervention1: CARDIO-India programme: The CARDIO-India programme is a co-created, technology-enabled, community and primary health system-based intervention aimed at improving early detection, treatm
and
(ii) a patient-facing mobile application (or in-person visits/text messaging/IVRS for older adults without smartphone access) to support self-management, adherence, and continuity of care.
The int
Sponsors
Centre for Chronic Disease Control
Eligibility
Inclusion criteria
Inclusion criteria: Participants will include older adults aged 60 years and above who have been diagnosed with hypertension (systolic blood pressure more than or equal to 140 mmHg or diastolic blood pressure more than or equal to 90 mmHg, with or without antihypertensive treatment) and are accessing healthcare services for hypertension management from the Mobile Healthcare Units (MHUs) operated by HelpAge India.
Exclusion criteria
Exclusion criteria: Participants who are unable to provide informed consent and those with serious or terminal illnesses that would impede their ability to participate in study procedures or follow-up assessments, will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in mean delta change of SBP between both armsTimepoint: Primary outcome will be measured at baseline, 12-month and 24-month intervals | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean change in the physical component score as measured by SF-12Timepoint: Measured at baseline, 12-month and 24-month follow-up periods;Mean change in the cardiovascular disease (CVD) risk assessed by the WHO CVD Risk Chart adapted for the Southeast Asia RegionTimepoint: Measured at baseline, 12-month and 24-month follow-up periods;Change in proportion of older people achieving hypertension controlTimepoint: Measured at baseline, 12-month and 24-month follow-up periods;Change in proportion of older people achieving glycaemic controlTimepoint: Measured at baseline, 12-month and 24-month follow-up periods;Change in proportion of older people achieving hyperlipidaemia (total cholesterol less than 190mg/dl) controlTimepoint: Measured at baseline, 12-month and 24-month follow-up periods;Change in proportion of older people with overweight/obesityTimepoint: Measured at baseline, 12-month and 24-month follow-up periods;Mean change in self-management (self-efficacy, adherence to treatment recommendations, changes in tobacco use/smoking, physical activity levels, alcohol use)Timepoint: Measured at baseline, 12-month and 24-month follow-up periods;Change in proportion of older people with depression assessed by PHQ-9Timepoint: Measured at baseline, 12-month and 24-month follow-up periods;Mean change in the Quality of Life (QoL) assessed by EuroQol 5 dimensions (EQ-5D) 3-level versionTimepoint: Measured at baseline, 12-month and 24-month follow-up periods;Outcomes related to the care processes (Change in proportion of medication use, healthcare access and utilisation, hospitalisations)Timepoint: Measured at baseline, 12-month and 24-month follow-up periods;Mean change in multidimensional indices of function measured by the WHO Disability Assessment ScheduleTimepoint: Measured at baseline, 12-month and 24-month follow-up periods;Mean change in the fried Index and activities of daily livingTimepoint: Measured at baseline, 12-month and 24-month follow-up periods | — |
Countries
India
Contacts
Public ContactProf Sailesh Mohan
Centre for Chronic Disease Control
Outcome results
None listed